PPT-EULAR recommendations for the use of imaging in

Author : pasty-toler | Published Date : 2019-11-07

EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice Target populationquestion 2 26318 Target population

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "EULAR recommendations for the use of ima..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

EULAR recommendations for the use of imaging in: Transcript


EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice Target populationquestion 2 26318 Target population patients with suspected or diagnosed axial or peripheral. Traditionally clinical imaging exploits the contrast due to differences in spin density spinlattice relaxation T and spinspin relaxation T between normal tissues and pathology However other contrast mechanisms such as susceptibility magnetization Scientific Committee. Majed. . Khraishi. , MD. St. John's, NF. Janet Pope, MD. London, ON. Anthony Russell, MD. Edmonton, AB. Participants. Carole Bertrand, MD. Terrebonne, QC. Louis Bessette, MD. Quebec, QC. Katerina . Dikaiou. FP7/FMTXCT. Florian Stuker SNF. Steffi Lehmann NCCR/SNF. Divya. . Vats. FP7/LIVIMODE. Sandra . Buergi. NCCR/SNF. Manoj. . Desai. . FP7/LIVIMODE. Markus . Rudin. Institute . for. and . the . management of . family . planning, . assisted reproduction. , pregnancy and menopause . in . patients with . systemic lupus erythematosus . and/or . antiphospholipid . syndrome. L . Andreoli. Published Simultaneously in the October 2015 Issues of . A&R . and . ARD. Intent of Gout Classification Criteria. To identify, in a standardized manner, a relatively homogeneous group of individuals with gout for enrollment into clinical studies. for. . the. . management. . of. . psoriatic. . arthritis. : 2015 update. Objective. Target . population. : . patients. . with. . psoriatic. . arthritis. (PsA). Objective. : . to. update . the. EULAR points to consider for reporting /screening and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice : a EULAR initiative * * Baillet A, Aim. 2. 05/11/2018. Giant cell arteritis (GCA): most common primary systemic vasculitis in western countries. Lifetime risk: 1.0% for women and 0.5% for men over the age of 50 years. Severe potential complications: sight loss, stroke, cranial nerve palsy, large-vessel aneurysms, vascular . Chairs: Karim Raza, Birmingham & Diane van der . Woude. , Leiden. Goals:. provide a platform for investigators involved in risk factors for RA and “pre-RA” . allow the exchange of ideas and foster new collaborations. Slide 1: Target population/question. 2. 26/02/2019. In 2006, the EULAR produced its first evidence-based recommendations for the diagnosis of gout. Since then, a number of studies have explored the diagnostic value of clinical algorithms and of imaging modalities such as ultrasound (US) or dual-energy computed tomography (DECT). This prompted a revision of the 2006 recommendations following an updated systematic literature review (SLR) and a Delphi process to achieve consensus. Slide 1: . Target. population/question. 2. 09/01/2018. Patients with inflammatory joint disorders, particularly rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. To update the EULAR 2009 cardiovascular disease (. Introduction. 2. 09/08/2018. Rheumatic and musculoskeletal diseases (RMD) that start in childhood can continue into adulthood, and young people (YP) with continuing disease are at risk of ill health.. Dimitrios. T. . Boumpas. (. leader. ), George Bertsias (. facilitator. ), on behalf of the Study Group members. The EULAR study Group on SLE was established in 2011 and has the following . objectives. The initiative primarily set out to guide clinicians, mainly . rheumatologists, but also in some countries internists and immunologists, who have to play a pivotal role in developing with the oncologists a patient-centred approach to improve the diagnosis and the management of rheumatic immune-related adverse events (irAEs)..

Download Document

Here is the link to download the presentation.
"EULAR recommendations for the use of imaging in"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents